Clinical Trials in Geelong, Australia
Locations / Geelong, Australia
Delta Trials records 465 clinical trials conducted in Geelong, Australia, making it a notable site of clinical research activity. These trials across 405 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 51 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Geelong has changed over time.
465
Total Trials
405
Conditions
51
Terminated since 2020
Browse by condition (405 total)
- Breast cancer 25 trialsAll Breast cancer trials
- Non-small cell lung cancer 14 trialsAll Non-small cell lung cancer trials
- Type 2 diabetes mellitus 13 trialsAll Type 2 diabetes mellitus trials
- Multiple myeloma 11 trialsAll Multiple myeloma trials
- Rheumatoid arthritis 11 trialsAll Rheumatoid arthritis trials
- Heart failure 10 trialsAll Heart failure trials
- Obesity 10 trialsAll Obesity trials
- Type 2 diabetes 9 trialsAll Type 2 diabetes trials
- Alzheimer's disease 9 trialsAll Alzheimer's disease trials
- Diabetes mellitus, type 2 8 trialsAll Diabetes mellitus, type 2 trials
- Acute coronary syndrome 8 trialsAll Acute coronary syndrome trials
- Atrial fibrillation 8 trialsAll Atrial fibrillation trials
- Overweight 7 trialsAll Overweight trials
- Chronic lymphocytic leukemia 7 trialsAll Chronic lymphocytic leukemia trials
- Dementia 6 trialsAll Dementia trials
- Stroke 6 trialsAll Stroke trials
- Prostate cancer 6 trialsAll Prostate cancer trials
- All Pulmonary disease, chronic obstructive trials
- Diffuse large B-cell lymphoma 6 trialsAll Diffuse large B-cell lymphoma trials
- All Respiratory syncytial virus infections trials